연구동향 분석

Simultaneous determination of tolterodine and its two metabolites, 5-hydroxymethyltolterodine and N-dealkyltolterodine in human plasma using LC?MS/MS and its application to a pharmacokinetic study

김영훈 변지영 김세형 이충민 정의현 채원기 장춘곤 이석용 이윤정 2017년

논문상세정보
    • 저자 김영훈 변지영 김세형 이충민 정의현 채원기 장춘곤 이석용 이윤정
    • 제어번호 105258604
    • 학술지명 Archives of Pharmacal Research
    • 권호사항 Vol. 40 No. 11 [ 2017 ]
    • 발행처 대한약학회
    • 발행처 URL http://www.psk.or.kr
    • 자료유형 학술저널
    • 수록면 1287-1295 ( 9쪽)
    • 언어 English
    • 출판년도 2017
    • 등재정보 KCI등재
    • 소장기관 영남대학교 중앙도서관 영남대학교 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관 중앙대학교 서울캠퍼스 중앙도서관
    • 판매처
    유사주제 논문( 0)
인용/피인용

' Simultaneous determination of tolterodine and its two metabolites, 5-hydroxymethyltolterodine and N-dealkyltolterodine in human plasma using LC?MS/MS and its application to a pharmacokinetic study' 의 참고문헌

  • Tolterodine: an overview
    Paper T World J Urol 19 312-318 [2001]
  • Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes
    Postlind H Drug Metab Dispos 26 289-293 [1998]
  • Simultaneous assay of multiple antibiotics in human plasma by LC-MS/MS:importance of optimizing formic acid concentration
    Chen F Bioanalysis 9 469-483 [2017]
  • Quantitative bioanalytical methods validation and implementation:best practices for chromatographic and ligand binding assays
    Viswanathan CT Pharm Res 24 1962-1973 [2007]
  • Pharmacogenetic prediction of individual variability in drug response based on CYP2D6, CYP2C9and CYP2C19 genetic polymorphisms
    Chaudhry SR Curr Drug Metab 15 711-718 [2014]
  • Ketoconazole inhibits the metabolism of tolterodine in subjects with deficient CYP2D6 activity
    Brynne N Br J Clin Pharmacol 48 564-572 [1999]
  • High-performance liquid chromatography-electrospray ionization mass spectrometric determination of tolterodine tartrate in human plasma
    Zhang B J Chromatogr B 824 92-98 [2005]
  • Functional gene variants of CYP3A4
    Werk AN Clin Pharmacol Ther 96 340-348 [2014]
  • Fluoxetine inhibits the metabolism of tolterodine—pharmacokinetic
    Halle B Br J Clin Pharmacol 48 553-563 [1999]
  • Fluoxetine inhibits the metabolism of tolterodinepharmacokinetic implications and proposed clinical relevance
    Brynne N Br J Clin Pharmacol 48 553-563 [1999]
  • Efficacy and safety of tolterodine in patients with detrusor instability: a dose-ranging study
    Rentzhog L Br J Urol 81 42-48 [1998]
  • Effects of the CYP2D6*10 allele on the pharmacokinetics of atomoxetine and its metabolites
    변지영 Archives of Pharmacal Research 38 11 2083-2091 [2015]
  • Effects of CYP2C9*1/*3 genotype on the pharmacokinetics of flurbiprofen in Korean subjects
    이윤정 Archives of Pharmacal Research 38 6 1232-1237 [2015]
  • Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of zafirlukast
    이현지 Archives of Pharmacal Research 39 7 1013-1019 [2016]
  • Effects of CYP2C9 genetic polymorphisms on the pharmacokinetics of celecoxib and its carboxylic acid metabolite
    김세형 Archives of Pharmacal Research 40 3 382-390 [2017]
  • Determination of tolterodine and the 5-hydroxymethyl metabolite in plasma, serum and urine using gas chromatography-mass spectrometry
    Palme´r L J Pharm Biomed Anal 16 155-165 [1997]
  • Determination of tolterodine and its 5-hydroxymethyl metabolite in human plasma by hydrophilic interaction liquid chromatography—tandem mass spectrometry
    Macek J J Chromatogr B 877 968-974 [2009]
  • Comparison of peak shape in hydrophilic interaction chromatography using acidic salt buffers and simple acid solutions
    Heaton JC J Chromatogr A 1347 39-48 [2014]
  • A new rapid and sensitive stability-indicating UPLC assay method for tolterodine tartrate: application in pharmaceuticals, human plasma and urine samples
    Yanamandra R Sci Pharm 80 101-114 [2012]